Full-Time

Events Marketing Manager

Posted on 12/20/2024

iRhythm Technologies

iRhythm Technologies

1,001-5,000 employees

Advanced cardiac monitoring solutions provider

Compensation Overview

$104.2k - $135kAnnually

Expert

Remote in USA

Candidates must be based in the United States.

Category
General Marketing
PR & Communications
Growth & Marketing
Required Skills
Lead Generation
Requirements
  • Bachelor’s degree in marketing, communications, event management, or a related field; advanced degree a plus.
  • 10+ years of experience in event management, ideally within the healthcare or med-tech industry.
  • Demonstrated success in the development and planning of strategic events, executing large scale industry tradeshows, sales meetings, and regional events with measurable business impact.
  • Strong organizational, project management, and budgeting skills, with the ability to manage multiple events simultaneously.
  • Excellent interpersonal, negotiation, and communication skills to effectively engage with internal and external stakeholders.
  • Proficiency with event management software, CRM, and project management tools.
  • Ability to travel domestically, as required, to oversee event execution.
Responsibilities
  • Develop and implement a comprehensive events strategy that aligns with company goals, brand positioning, and commercial objectives.
  • Design event programs that meet targeted business needs, support sales goals, and promote customer engagement and growth.
  • Serve as an advisor to leadership, providing insights on trends, best practices, and innovation in event strategy.
  • Oversee all aspects of event management, including venue selection, vendor negotiations, budget management, on-site coordination, and post-event analysis.
  • Ensure smooth execution of events, including logistics, registrations, travel arrangements, audiovisual needs, and vendor management.
  • Manage relationships with third-party vendors, maintaining the highest standards of service, while adhering to company policies and compliance requirements.
  • Partner closely with cross-functional teams including sales, marketing, product management, and regional teams to align event objectives and deliver cohesive messaging.
  • Collaborate with Marketing and Commercial Strategy teams to enhance pre- and post event engagement and maximize lead generation and follow-up.
  • Develop and manage event budgets, ensuring alignment with financial objectives and accurate financial reporting.
  • Measure and report on event outcomes, including ROI, lead generation, brand impact, and attendee satisfaction.
  • Continuously optimize event processes and strategies based on feedback, metrics, and industry best practices.

iRhythm Technologies focuses on cardiac monitoring solutions, with its main product being the Zio Patch, a wearable device that tracks heart rhythms for up to 14 days. This extended monitoring helps healthcare providers detect irregular heart rhythms that shorter monitoring periods might miss. Patients can use the Zio Patch to monitor their heart activity conveniently, reducing the need for frequent office visits, which is especially beneficial in a telehealth environment. The company stands out by offering comprehensive data analysis services alongside the device, providing actionable insights to healthcare providers.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

San Francisco, California

Founded

2006

Simplify Jobs

Simplify's Take

What believers are saying

  • iRhythm's European expansion aligns with continuous ECG monitoring guidelines.
  • Growing demand for cardiac monitoring due to rising cardiovascular disease prevalence.
  • Remote patient monitoring trend supports Zio Patch's market potential.

What critics are saying

  • Increased competition from AI-driven cardiac monitoring startups.
  • FDA warning letter may lead to regulatory scrutiny and fines.
  • Shareholder investigation could result in legal challenges and financial liabilities.

What makes iRhythm Technologies unique

  • Zio Patch offers up to 14 days of continuous cardiac monitoring.
  • iRhythm's integration with AI enhances arrhythmia detection accuracy and efficiency.
  • Exclusive license with BioIntelliSense expands iRhythm's product offerings.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Mental Health Support

Hybrid Work Options

Pet Insurance

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

0%
Investing.com
Feb 28th, 2025
iRhythm technologies' CBO and CLO Murphy sells $1.79 million in stock

Additionally, iRhythm is expanding internationally, with early launches in Europe and plans to enter the Japanese market in mid-2025.

Yahoo Finance
Jan 13th, 2025
Irhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights And Business Update At The 43Rd Annual J.P. Morgan Healthcare Conference

iRhythmSAN FRANCISCO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quarter operational highlights and a business update at the 43rd Annual J.P. Morgan Healthcare Conference.Recent Operational Highlights and Financial OutlookAnticipate full year 2024 revenue slightly above high end of previously stated guidance range of $587.5 million provided in October 2024Record quarter of new account openings for both Zio monitor and Zio AT during the fourth quarter 2024 as well as strong volume contributions from large national accountsLaunched first four health care systems on Epic Aura during the fourth quarter 2024 with broad commercial roll out for Epic health systems across the U.S. beginning in 2025Initiated Zio monitor shipments for home enrollment patients during the fourth quarter 2024Five studies presented at the American Heart Association highlight Zio Monitor’s high patient satisfaction, engagement and compliance with the patient MyZio app and digital tools, health economic impact of early arrhythmia detection in type 2 diabetes and respiratory disease, and AI insights on sleep and activity patterns 1Expect revenue for the full year 2025 of approximately $675 million to $685 million“This past year was a period of significant growth and transformation for iRhythm,” said Quentin Blackford, iRhythm’s President and CEO. “In our core U.S

MarketBeat
Nov 26th, 2024
Dynamic Technology Lab Private Ltd Invests $1.50 Million in iRhythm Technologies, Inc. (NASDAQ:IRTC)

Dynamic Technology Lab Private Ltd invests $1.50 million in iRhythm Technologies, Inc. (NASDAQ:IRTC).

MPO Magazine
Oct 22nd, 2024
iRhythm Earns FDA Nod for Zio AT After Warning Letter

The letter accused iRhythm of violating Federal Food, Drug, and Cosmetic Act rules about labeling, medical device reporting, and quality systems.

Global Tech Times
Sep 20th, 2024
Kaskela Law LLC Announces Shareholder Investigation of iRhythm Technologies, Inc. (NASDAQ: IRTC) and Encourages Long-Term IRTC Shareholders to Contact the Firm

Recently a securities fraud complaint was filed against iRhythm on behalf of investors who purchased shares of the company's stock between November 5, 2021 and May 30, 2023 (the "Class Period").

INACTIVE